The lab’s central interests are describing and understanding genomic regulation, its diversity, and its impact on health and disease.
The lab’s central interest is the development of algorithms and software solutions for genomics research.
Vivan Therapeutics is a UK-based biotechnology company specializing in personalized cancer therapies. ABI supports Vivan Therapeutics in its mission to develop a personalized drug discovery process for its patients.
Together with the scientists at Agenus, ABI will form a team of students and researchers to study cancer metastases and identify potential biomarkers and targets for cancer immunotherapies.This collaboration is also part of our long-term vision of supporting biotech developments in Armenia.